Clinical Trial Update: Symptom-specific TMS Targets for Depression and Anxiety [Phase 2]

View source ↗

Summary

Phase 2 trial updating on symptom-specific transcranial magnetic stimulation targets for depression and anxiety has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anxiety Disorders
• Major Depressive Disorder

Drugs mentioned

• Transcranial Magnetic Stimulation (TMS)

Snippet

Sponsor: Brigham and Women's Hospital | Conditions: Depression, Anxiety | Phase 2 | Status: COMPLETED